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Objectives: The aim of the theoretical part of this diploma thesis was the analysis of the 
counterfeiting of medicinal products and a summary of the most critical topics and issues 
related to this illegal activity. Another purpose of the theoretical part was the mapping of 
trends in counterfeiting of medicinal products on the domestic and world scale and to 
compile a summary of the instruments used to combat counterfeiting of medicinal 
products. The aim of the practical part was the analysis of the reports of falsified 
medicinal products and to compare the obtained results with hypotheses based on 
theoretical knowledge. 
Methods: The data was obtained by analyzing the reports of counterfeit medicinal 
products published by State Institute for Drug Control in the period from 2nd March 2006 
to 14th November 2017. Altogether, 115 reports from the Czech Republic and from abroad 
were analyzed. 
Results: The results of the analysis show that the situation regarding counterfeiting of 
medicinal products in the Czech Republic is relatively safe compared to foreign countries 
and that none have been detected counterfeits appeared in the legal market. Also, the 
results show that counterfeiters are interested in expensive medicines from cytostatics and 
antivirals. In addition, it can be confirmed that counterfeiting of medicinal products is  
a global problem affecting both developing and advanced countries, and that any drug 
can be counterfeited. 
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